InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by PRESTRELSKI STEVEN. Director active across 2 companies, notably Xeris Biopharma Holdings, Inc.. Aggregated, 7 filings have been logged. History available since 3 January 2022. The latest transaction was disclosed on 22 February 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
11,228 shares@ US$0.690.0005% mcap100.0% of flowCommon StockSEC:0001867096-22-000025:0
75,000 shares0Common StockSEC:0001867096-22-000006
75,000 shares0Common StockSEC:0001867096-22-000006:0
384,780 sharesCommon StockSEC:0000899243-21-039249:0
384,780 sharesCommon StockSEC:0000899243-21-039330
384,780 sharesCommon StockSEC:0000899243-21-039330:0
384,780 sharesCommon StockSEC:0000899243-21-039249
7 of 7 declarations
About PRESTRELSKI STEVEN
Steven Prestrelski is a director at Xeris Biopharma Holdings, Inc. and Xeris Pharmaceuticals INC.
